Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
13,913,023
-
Shares change
-
-576,630
-
Total reported value, excl. options
-
$835,272,340
-
Value change
-
-$16,214,267
-
Put/Call ratio
-
0%
-
Number of buys
-
52
-
Number of sells
-
-40
-
Price
-
$60.00
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2020
121 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q4 2020.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,913,023 shares
of 29,067,614 outstanding shares and own 48% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (1,675,036 shares), BlackRock Inc. (1,407,348 shares), FMR LLC (1,252,386 shares), FRAZIER MANAGEMENT LLC (895,000 shares), CREDIT SUISSE AG/ (775,516 shares), VANGUARD GROUP INC (739,138 shares), BAKER BROS. ADVISORS LP (698,874 shares), STATE STREET CORP (560,250 shares), FARALLON CAPITAL MANAGEMENT LLC (525,000 shares), and Point72 Asset Management, L.P. (500,000 shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.